Acumen Fund invests patient capital in breakthrough businesses that provide the world's poor with basic goods and services. Sproxil is a social enterprise that uses technology to help consumers verify the authenticity of their medication to avoid the use of counterfeit pharmaceuticals. Acumen Fund’s USD 1.79 million investment will support Sproxil’s expansion into India, evaluate expansion into East Africa, and develop further improvements in its technology.
About the Global Impact Investing Network
The Global Impact Investing Network is the global champion of impact investing, dedicated to increasing its scale and effectiveness around the world. Impact investments are investments made with the intention to generate positive, measurable social and environmental impact alongside a financial return.